NCT06586918

Brief Summary

To evaluate the association between the Perfusion index parameter and an independent measure of perfusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

September 4, 2024

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 13, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
Last Updated

October 26, 2024

Status Verified

September 1, 2024

Enrollment Period

9 days

First QC Date

September 4, 2024

Last Update Submit

October 23, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Perfusion Index (PI) correlation to doppler measurement

    To confirm correlation of Perfusion Index measured by the investigational pulse oximeter PCBA and Market Released sensors to the laser doppler measure of skin perfusion (LDSP) as determined by an overall instantaneous (lag(0)) Spearman rank correlation.

    1 hour

Study Arms (1)

Healthy Volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy Male or Female volunteers age ≥18 years, weighing greater than 40kgs.

You may qualify if:

  • Subjects ≥18 years of age
  • Subject is able to participate for the duration of the study
  • Subject is willing to sign an informed consent
  • Subject weighs \>40kg

You may not qualify if:

  • Previous injury or trauma to fingers or hands that may change blood flow or vascular supply and affect the ability to test sensors
  • Physiologic abnormalities that prevent proper application of pulse oximetry sensor
  • Severe contact allergies that cause a reaction to standard adhesive materials such as those found in medical sensors and electrodes.
  • Raynaud Syndrome
  • Repeated systolic blood pressure \> 140mmHg -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medtronic Clinical Physiology Lab

Denver, Colorado, 80218, United States

Location

Study Officials

  • Randall M Clark, M.D.

    Medtronic Clinical Physiology Lab

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2024

First Posted

September 19, 2024

Study Start

September 4, 2024

Primary Completion

September 13, 2024

Study Completion

September 13, 2024

Last Updated

October 26, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations